Triple I News: Infectious Disease, Immunity and Inflammation Clinical Academic Group

No images? Click here

Maridulu Budyari Gumal

TRIPLE I NEWS

Triple I Clinical Academic Group: Infectious Disease, Immunity and Inflammation
Maridulu Budyari Gumal SPHERE: Sydney Partnership for Health, Education, Research and Enterprise 

4 JUNE 2021

 
 
 
 
 

News 

 


Triple I Seed Grants - Expressions of Interest closing soon
Expressions of Interest are invited for the following Triple I (Infectious Disease, Immunity & Inflammation) seed grants: 

  • 1 x Triple I SPHERE Clinical Academic Group grant of up to $75K
  • 2 x Triple I UNSW Theme grants of up to $75K

Up to four EOIs will be selected for progression to a collaborative workshop and project plan development, with funding awarded based on reviews of final project plans. Please see the EOI guidelines and application for further information. Submit EOI and enquiries  to: medicine.themes@unsw.edu.au

EOI Deadline: 20 June 2021 (midnight)
EOI Application
 

 


Leading cancer researchers converge on UNSW for inaugural Cancer Immunology Ideas Forum
During the forum, scientists and clinicians discussed cancer immunotherapy, CAR-T cells and difficult-to-target malignancies – brainstorming about where this fast-moving field is headed.
Read more
 

 


What we've learned about managing COVID-19 pneumonia
How we now treat COVID-19 pneumonia compared to 12 months ago makes a significant difference to survival. 
Read more
 

 


Scientists find new way of predicting COVID-19 vaccine efficacy
Australian researchers have identified the immune response associated with protection from COVID-19 – a discovery that may help cut the time it takes to develop new vaccines.
Read more
 

 


Research collaboration addresses COVID-19 myths in African communities
Western Sydney University academics, A/Prof Kingsley Agho and Dr Levi U Osuagwu, have led an international research collaboration assessing the impact of COVID-19 on the world’s African communities.
Read more
 

 


We need herd immunity against COVID-19 vaccine misinformation
Misleading claims about COVID-19 vaccines can negatively impact public confidence in immunisation uptake, a new UNSW Sydney study reveals.
Read more
 

 


The complete sequence of a human genome
The Telomere-to-Telomere (T2T) Consortium has finished the first truly complete 3.055 billion base pair (bp) sequence of a human genome, representing the largest improvement to the human reference genome since its initial release.
Read the pre-print
 

 
 
 
 
 

Events & Opportunities 

 


Kirby Institute Seminar Series
Vaccines and biodefense: COVID-19, flu and beyond. Professor Nikolai Petrovsky
Research Director, Vaxine Pty Ltd and Professor of Medicine, Flinders University
When: 8 June 2021
Read more
 

 


Job Opportunity: Research Assistant/Officer
Research Assistant/Officer, Level 5 or 6 at the Kirby Institute Immunovirology & Pathogenesis Program (IVPP). The role is full time, fixed term for 12 months. 
Closing date: 15 June 2021
Read more
 

 


Webinar: Impacts of COVID-19 on international research collaboration
This event will be a broad discussion on the impacts of the COVID-19 pandemic on scientific research and international cooperation. Hosted by Australian Academy of Science Chief Executive, Anna-Maria Arabia.
When: 22 June 2021
Read more
 

 


ESID 2021
The European Society of Immunodeficiencies Multidisciplinary Symposium on the Immunological Consequences of Targeted Immune Therapies (ESID 2021) will take place online, focussing on topics including B/plasma cell depleting therapies, secondary immunodeficiencies and COVID-19.
When: 27 - 29 September 2021
Read more
 

 


Expression of Interest – MRFF Grant Assessment Committee
The Department of Health is seeking interest from a range of stakeholders to assist in MRFF grant review and assessment processes as a member of a Grant Assessment Committee for a number of 2020-21 MRFF grant opportunities.  
Read more
 

 


National COVID-19 Bereavement project - survey
UTS researchers seek study participants who have experienced bereavement due to any cause during the COVID-19 pandemic. Research findings will inform a National Bereavement Action Plan for this and any future pandemics.
Access the survey  
 

 
 
 
 

Funding

 


Snow Fellowship
Snow Fellowships develop Australia’s next generation of outstanding biomedical research leaders. Fellowships are valued at approximately $8M over eight years for eligible early to mid-career researchers, with funding to set up and operate a research laboratory.
EOI Deadline: 7 July 2021
Read more

 
 


2021 GSK Award for Research Excellence
Nominations are open for the GSK Award for Research Excellence, available to Australian medical researchers. A grant of $80K accompanies the award, helping the winner further their contributions. 
Deadline: 30 July 2021
Read more
 

 


Arthritis Australia Grants 2022
Applications are open for a range of Arthritis Australia 2022 funding opportunities including:

  • Aboriginal and Torres Strait Islander fellowship
  • Ken Muirden overseas training fellowship 
  • Project Grant for translational research
  • ARA Project Grants

Deadline:  9 July 2021
Read more

 
 


Open NHMRC and MRFF Funding Opportunities

  • Development Grants Deadline: 16 June 2021
  • Partnership Project 2021 PRC2 Deadline: 12 August 2021
  • MRFF – 2021 COVID 19 Health Impacts and Vaccination Schedules Grant Opportunity Deadline: 18 August 2021
  • MRFF 2021 Rare Cancers Rare Diseases Unmet Need General - Grant Opportunity Deadline: 18 August 2021
  • MRFF 2021 International Clinical Trial Collaborations (ICTC) Grant Opportunity  Deadline: 8 September 2021

NHMRC Funding Calendar
​MRFF Funding Calendar 
 

 
 
 
 

Triple I Vision: A world where human health is enriched by controlling infection, enhancing immunity and managing inflammation.

Subscribe
 
 
  Forward 
Triple I Clinical Academic Group
Infectious Disease, Immunity and Inflammation 
UNSW Sydney
r.puls@unsw.edu.au
You have received this newsletter because you are employed by or affiliated with a TRIPLE I Clinical Academic Group partner.
Preferences  |  Unsubscribe